To the Editor: Lung cancer screening is a controversial issue, as clearly discussed by Hew and colleagues, who focus on the high false-positive rate, generalisability and cost.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Hew M, Stirling RG, Abramson MJ. Should we screen for lung cancer in Australia? Med J Aust 2013; 199: 82-83. <MJA full text>
- 2. United States Preventive Services Task Force. Screening for lung cancer. Draft recommendation statement. Agency for Healthcare Research and Quality publication no. 13-05196-EF-3. http://www. uspreventiveservices taskforce.org/uspstf13/lungcan/lung candraftrec.htm (accessed Aug 2013).
- 3. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013; 369: 245-254.
- 4. Marshall HM, Bowman RV, Crossin J, et al. Queensland Lung Cancer Screening Study: rationale, design and methods. Intern Med J 2013; 43: 174-182.
- 5. Tammemägi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013; 368: 728-736.
- 6. Australian Population Health Development Principal Committee Screening Subcommittee. Population based screening framework. Canberra: Australian Government Department of Health and Ageing, 2008.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.